High materiality7/10
10x Genomics price target raised to $40 from $30 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lifts TXG target to $40; current price $31.87, leaving room for upside toward the new target.
- Target increased to $40; price below target; upside remains.
Key facts
- 01
Target: $40
- 02
Posted price: $31.87
- 03
Analyst firm: Barclays
- 04
Analyst: Luke Sergott
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.